Abaloparatide
Tymlos
- Peptide length
- 34 amino acids
Modified PTHrP-related peptide
Open the sources to check how the studies were done and what they can support.
A PTHrP-related analog with randomized fracture-prevention research in postmenopausal osteoporosis.
- Family
- PTHrP analog
- Research target
- PTH type 1 receptor
- Molecular form
- Modified PTHrP-related peptide
What to know about the research
The ACTIVE trial supports a specific osteoporosis context; apparent differences from another agent require attention to trial design and endpoints.
Check the exact compound
Abaloparatide and teriparatide share a receptor pathway but have different sequences and product labeling.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries